Dr Frederik Marmé is a gynaecologic oncologist at the University Hospital Mannheim and the Medical Faculty Mannheim of Heidelberg University, Germany. He studied medicine at the Albert-Ludwigs University, Freiburg, Germany; King´s College London Medical School, London, UK; and the Ruprecht-Karls-University, Heidelberg, Germany – from which he graduated in 2002. He then worked as a post-doctoral researcher at the German Cancer Research Center in Heidelberg.

Since his residency at the Heidelberg University Hospital, Dr Marmé focused on translational research and systemic therapy of breast and gynaecologic cancers. He achieved his board certificate in obstetrics and gynaecology in 2010 and served as a consultant in breast and gynaecologic oncology at the National Center for Tumor Diseases (NCT) in Heidelberg. Dr Marmé became an Assistant Professor at Heidelberg University in 2014 and in 2019 was made Professor of Experimental and Translational Gynecologic Oncology at the Medical Faculty. He is Head of the Section Conservative Gynecologic Oncology and the Gynecologic Clinical Trials Unit at the University Hospital Mannheim.

Dr Marmé is co-chair of the AGO Study Group and member of the Scientific Board of the German Breast Group (GBG). His translational research is focused on the exploitation of DNA damage repair and synthetic lethality in gynaecological malignancies, the modulation of the tumour-microenvironment and patient-derived 3D cell culture models, all of which are investigated as part of the AGO-OVAR 27 study. He has led numerous trials as national and international Coordinating Investigator, and is the international Principal Investigator of the phase III GBG102/SASCIA study, investigating sacituzumab govitecan in post-neoadjuvant HER2-negative breast cancer.

Dr Marmé has authored numerous papers published in peer-reviewed international journals and has been an invited speaker at several international meetings. He has also collaborated on various international publications (books) as an author and editor and serves as an Associate Editor for Cancer Investigation journal. Dr Marmé has served as a member of the European Society of Medical Oncology (ESMO) Faculty group for gynaecologic cancers since 2021 and has been a member of the Scientific Committee for several ESMO congresses and meetings. He has joined the ESMO Educational Publications Working Group in January 2024.